FA
IDYA icon

Fountainhead AM’s IDEAYA Biosciences IDYA Stock Holding History

Fountainhead AM’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-64,901
Closed -$1.77M – 198
2025
Q3 		$1.77M Hold
64,901
– – 0.23% 55
2025
Q2 		$1.36M Hold
64,901
– – 0.2% 53
2025
Q1 		$1.06M Buy
64,901
+345
+0.5% +$7.35K 0.17% 50
2024
Q4 		$1.66M Buy
+64,556
New +$1.83M 0.3% 43

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fountainhead AM's IDYA Position: Q4 2025 in Review

Fountainhead AM sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 64,901 shares — an estimated $1.77M sold.

Fountainhead AM first reported a position in IDYA in Q4 2024 and held it in 4 quarters. The position peaked at $1.77M in Q3 2025. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

  • Fountainhead AM reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
  • Fountainhead AM sold 64,901 IDEAYA Biosciences shares in Q4 2025, an estimated $1.77M.
  • Fountainhead AM first reported a position in IDEAYA Biosciences in Q4 2024 and held it in 4 quarters.
  • Fountainhead AM's IDEAYA Biosciences position peaked at $1.77M in Q3 2025.
  • 246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Fountainhead AM's 13F filing for Q4 2025, filed 18 Feb 2026.